title: The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel.
abstract: TRPML1 (mucolipin 1, also known as MCOLN1) is predicted to be an intracellular late endosomal and lysosomal ion channel protein that belongs to the mucolipin subfamily of transient receptor potential (TRP) proteins. Mutations in the human TRPML1 gene cause mucolipidosis type IV disease (ML4). ML4 patients have motor impairment, mental retardation, retinal degeneration and iron-deficiency anaemia. Because aberrant iron metabolism may cause neural and retinal degeneration, it may be a primary cause of ML4 phenotypes. In most mammalian cells, release of iron from endosomes and lysosomes after iron uptake by endocytosis of Fe(3+)-bound transferrin receptors, or after lysosomal degradation of ferritin-iron complexes and autophagic ingestion of iron-containing macromolecules, is the chief source of cellular iron. The divalent metal transporter protein DMT1 (also known as SLC11A2) is the only endosomal Fe(2+) transporter known at present and it is highly expressed in erythroid precursors. Genetic studies, however, suggest the existence of a DMT1-independent endosomal and lysosomal Fe(2+) transport protein. By measuring radiolabelled iron uptake, by monitoring the levels of cytosolic and intralysosomal iron and by directly patch-clamping the late endosomal and lysosomal membrane, here we show that TRPML1 functions as a Fe(2+) permeable channel in late endosomes and lysosomes. ML4 mutations are shown to impair the ability of TRPML1 to permeate Fe(2+) at varying degrees, which correlate well with the disease severity. A comparison of TRPML1(-/- )ML4 and control human skin fibroblasts showed a reduction in cytosolic Fe(2+) levels, an increase in intralysosomal Fe(2+) levels and an accumulation of lipofuscin-like molecules in TRPML1(-/-) cells. We propose that TRPML1 mediates a mechanism by which Fe(2+) is released from late endosomes and lysosomes. Our results indicate that impaired iron transport may contribute to both haematological and degenerative symptoms of ML4 patients.
authors.affiliation: The Department of Molecular, Cellular, and Developmental Biology, The University of Michigan, 3089 Natural Science Building (Kraus), 830 North University, Ann Arbor, Michigan 48109, USA.
authors.forename: Xian-Ping
authors.initials: XP
authors.lastname: Dong
authors.forename: Xiping
authors.initials: X
authors.lastname: Cheng
authors.forename: Eric
authors.initials: E
authors.lastname: Mills
authors.forename: Markus
authors.initials: M
authors.lastname: Delling
authors.forename: Fudi
authors.initials: F
authors.lastname: Wang
authors.forename: Tino
authors.initials: T
authors.lastname: Kurz
authors.forename: Haoxing
authors.initials: H
authors.lastname: Xu
mesh_terms: D000818:Animals; D002460:Cell Line; D002463:Cell Membrane Permeability; D011992:Endosomes / Q000378:metabolism*; D005347:Fibroblasts; D005453:Fluorescence; D006801:Humans; D017136:Ion Transport; D007501:Iron / Q000032:analysis / Q000378:metabolism*; D008247:Lysosomes / Q000378:metabolism*; D051379:Mice; D009081:Mucolipidoses / Q000378:metabolism*; D011522:Protons; D050053:TRPM Cation Channels / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D014162:Transfection; D050051:Transient Receptor Potential Channels
chemical_list: C416674:MCOLN1 protein, human; C512321:Mcoln1 protein, mouse; D011522:Protons; D050053:TRPM Cation Channels; D050051:Transient Receptor Potential Channels; D007501:Iron
references.citation: J Clin Invest. 2005 May;115(5):1258-66
references.pmid: 15849611
references.citation: Histochem Cell Biol. 2008 Apr;129(4):389-406
references.pmid: 18259769
references.citation: Hum Mol Genet. 2000 Oct 12;9(17):2471-8
references.pmid: 11030752
references.citation: Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14994-9
references.pmid: 12403827
references.citation: Pediatr Res. 1995 Jun;37(6):687-92
references.pmid: 7651750
references.citation: Am J Physiol Cell Physiol. 2006 Sep;291(3):C445-55
references.pmid: 16611735
references.citation: Neuropediatrics. 2002 Aug;33(4):199-202
references.pmid: 12368990
references.citation: Physiol Rev. 2007 Jan;87(1):165-217
references.pmid: 17237345
references.citation: Nature. 2003 Dec 4;426(6966):517-24
references.pmid: 14654832
references.citation: Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18321-6
references.pmid: 17989217
references.citation: PLoS Biol. 2004 Mar;2(3):E50
references.pmid: 15024413
references.citation: J Biol Chem. 2006 Jun 23;281(25):17517-17527
references.pmid: 16606612
references.citation: Traffic. 2006 Oct;7(10):1388-98
references.pmid: 16978393
references.citation: J Neurosci. 2002 Jul 15;22(14):5848-55
references.pmid: 12122047
references.citation: Cell. 2004 Apr 30;117(3):285-97
references.pmid: 15109490
references.citation: EMBO Rep. 2004 Sep;5(9):883-8
references.pmid: 15332114
references.citation: Neurology. 2002 Aug 13;59(3):306-13
references.pmid: 12182165
references.citation: Biochim Biophys Acta. 2007 Aug;1772(8):851-8
references.pmid: 17306511
references.citation: Mol Interv. 2006 Apr;6(2):89-97
references.pmid: 16565471
references.citation: Arch Biochem Biophys. 2000 Apr 1;376(1):74-81
references.pmid: 10729192
references.citation: Hum Mutat. 2004 Dec;24(6):460-5
references.pmid: 15523648
references.citation: Proc Natl Acad Sci U S A. 1998 May 26;95(11):6373-8
references.pmid: 9600972
references.citation: Annu Rev Physiol. 2007;69:69-85
references.pmid: 17014365
references.citation: J Biol Chem. 2007 Sep 14;282(37):27327-27333
references.pmid: 17609211
references.citation: Am J Hum Genet. 2000 Nov;67(5):1110-20
references.pmid: 11013137